JP2002518348A5 - - Google Patents

Download PDF

Info

Publication number
JP2002518348A5
JP2002518348A5 JP2000554404A JP2000554404A JP2002518348A5 JP 2002518348 A5 JP2002518348 A5 JP 2002518348A5 JP 2000554404 A JP2000554404 A JP 2000554404A JP 2000554404 A JP2000554404 A JP 2000554404A JP 2002518348 A5 JP2002518348 A5 JP 2002518348A5
Authority
JP
Japan
Prior art keywords
benzyl alcohol
water
concentration
prostaglandin
dinoprost tromethamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000554404A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002518348A (ja
JP4472175B2 (ja
Filing date
Publication date
Priority claimed from US09/094,985 external-priority patent/US6187818B1/en
Application filed filed Critical
Publication of JP2002518348A publication Critical patent/JP2002518348A/ja
Publication of JP2002518348A5 publication Critical patent/JP2002518348A5/ja
Application granted granted Critical
Publication of JP4472175B2 publication Critical patent/JP4472175B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000554404A 1998-06-17 1999-06-08 プロスタグランジンおよびベンジルアルコールを含む液剤 Expired - Lifetime JP4472175B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/094,985 US6187818B1 (en) 1998-06-17 1998-06-17 Prostaglandins formulation and process
US09/094,985 1998-06-17
PCT/US1999/011808 WO1999065527A1 (en) 1998-06-17 1999-06-08 Solution comprising prostaglandins and benzyl alcohol

Publications (3)

Publication Number Publication Date
JP2002518348A JP2002518348A (ja) 2002-06-25
JP2002518348A5 true JP2002518348A5 (https=) 2006-06-15
JP4472175B2 JP4472175B2 (ja) 2010-06-02

Family

ID=22248341

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000554404A Expired - Lifetime JP4472175B2 (ja) 1998-06-17 1999-06-08 プロスタグランジンおよびベンジルアルコールを含む液剤

Country Status (14)

Country Link
US (1) US6187818B1 (https=)
EP (1) EP1085907B1 (https=)
JP (1) JP4472175B2 (https=)
KR (1) KR100608176B1 (https=)
CN (1) CN1188170C (https=)
AT (1) ATE263576T1 (https=)
AU (1) AU752047B2 (https=)
CA (1) CA2331284C (https=)
DE (1) DE69916266T2 (https=)
DK (1) DK1085907T3 (https=)
ES (1) ES2219036T3 (https=)
NZ (1) NZ508947A (https=)
PT (1) PT1085907E (https=)
WO (1) WO1999065527A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE281432T1 (de) 1999-03-05 2004-11-15 Univ Duke C-16 ungesätigte fp-selektive prostaglandin analoge
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
CN108078998B (zh) * 2017-11-23 2018-09-21 宁波三生生物科技有限公司 一种氨基丁三醇前列腺素F2α注射液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3885041A (en) * 1970-12-28 1975-05-20 Searle & Co Antiinflammatory use of prostaglandins
US3917864A (en) 1973-02-12 1975-11-04 Sultanali M M Karim Use of prostaglandins E and F for induction of labor
US3903297A (en) 1973-11-01 1975-09-02 Upjohn Co Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs
EP0268066A3 (en) 1986-10-17 1990-07-11 Syntex (U.S.A.) Inc. Fertility control and uterine therapy in dogs with luteinizing hormone releasing hormone antagonists
AR002194A1 (es) 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.

Similar Documents

Publication Publication Date Title
JP3903061B2 (ja) 薬物を含有するナノ粒子およびその製造方法、ならびに当該ナノ粒子からなる非経口投与用製剤
US7094429B2 (en) Process for preparing tannate liquid and semi-solid dosage forms
JP2714464B2 (ja) 局所メトロニダゾール製剤
CA2567075C (en) Pharmaceutical suspension composition
WO2003017947A3 (en) Spontaneous emulsions containing cyclosporine
WO2004047801A3 (en) Method of drug loading in liposomes by gradient
TWI225401B (en) Solutions containing epinastin
JP2003506416A5 (https=)
RU97102139A (ru) Водные композиции рисперидона
JPH10287588A (ja) 医薬製剤
WO2003035051A3 (en) The use of proton sequestering agents in drug formulations
JP2002518348A5 (https=)
CN106727291A (zh) 一种盐酸托莫西汀口服溶液及其制备方法
JPH0825878B2 (ja) 局所的メトロニダゾール製剤
CN102065839A (zh) 包括米诺地尔的凝胶组合物
AU3080492A (en) Medicament containing a 2-arylpropionic acid derivate as a nanosol and its preparation
CA2370581A1 (fr) Nouvelles compositions pharmaceutiques comprenant des derives de 8-isoxazole-2-aminotetralines
WO1999052559A1 (fr) COMPOSITION OPHTALMIQUE COMPRENANT UN β-BLOQUANT
CA2326840A1 (en) Carvedilol-galenics
JP2003512330A (ja) シクレソニド含有水性医薬組成物
Wang et al. In‐vivo and in‐vitro evaluations of a modified‐release oral dosage form of nifedipine by hybridization of hydroxypropyl‐β‐cyclodextrin and hydroxypropylcelluloses in dogs
WO2004030665A1 (en) Transparent gel composition, for the administration of diclofenac sodium through the skin
CA2532648A1 (en) A stable clozapine suspension formulation
FR2680106A1 (fr) Procede de realisation de formes pharmaceutiques stables d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.
JPH0737386B2 (ja) 懸濁型ピレノキシン点眼剤